Connect your AI

SION SION Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Vertex PharmaceuticalsVRTX

——

Septerna, Inc.SEPN

——

BioCryst PharmaceuticalsBCRX

——

Denali Therapeutics Inc.DNLI

——

Other financials

Income statement

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

Market cap$1.86B—

Returns & leverage

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SION's accrued liabilities, current?: SION (SION) reported accrued liabilities, current of $6.33M in Q1 2026.
How has SION's accrued liabilities, current changed year-over-year?: SION's accrued liabilities, current increased by 86.7% year-over-year, from $3.39M to $6.33M.